Canon and Stereotaxis Collaborate to Advance Imaging and Robotic Navigation Technology

November 5, 2026—Canon Medical Systems USA and Stereotaxis announced a commercial collaboration that pairs Canon’s Alphenix interventional imaging platform with Stereotaxis’ GenesisX robotic magnetic navigation system. The companies will offer the systems in a compatible fashion alongside each other.

The press release stated that the Alphenix platform provides advanced imaging, visualization, dose-management, and workflow capabilities for interventional cardiology, with flexible configurations designed to support complex procedures.

The GenesisX is intended for robotic navigation of interventional catheters, with a semimobile architecture designed to facilitate adoption broadly within existing catheterization labs without any construction.

According to the companies, the combination of these technologies aims to expand access to next-generation robotic electrophysiology technology.

Canon and Stereotaxis will further explore opportunities for Alphenix and GenesisX to improve workflow and introduce advanced capabilities in electrophysiology. These efforts may apply beyond electrophysiology to support the advancement of robotic technology in interventional cardiology and neurointerventional procedures, advised the companies.